3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
9
Completed
8
Recruiting
6
Not yet recruiting
4
Terminated
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
629
Prostatic Neoplasms
372
Neoplasms
304
Carcinoma, Non-Small-Cell Lung
216
Lung Neoplasms
205
Colorectal Neoplasms
176
Multiple Myeloma
143
Pancreatic Neoplasms
135
Leukemia, Myeloid, Acute
129
Neoplasm Metastasis
124
Melanoma
116
Brain Neoplasms
116
Ovarian Neoplasms
101
Carcinoma, Hepatocellular
101
Precursor Cell Lymphoblastic Leukemia-Lymphoma
100
Glioblastoma
99
Uterine Cervical Neoplasms
97
Head and Neck Neoplasms
95
Squamous Cell Carcinoma of Head and Neck
93
Colonic Neoplasms
82
Stomach Neoplasms
81
Recurrence
80
Rectal Neoplasms
80
Urinary Bladder Neoplasms
77
Sarcoma
77
Triple Negative Breast Neoplasms
75
Carcinoma, Renal Cell
75
Lymphoma
71
Lymphoma, Non-Hodgkin
67
Myelodysplastic Syndromes
66
Interventions
Palliative Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
OTHER
×
Chemotherapy-Related Cognitive Impairment
×
Clear all
NCT04586530
2026-01-21
TAMS
University of Pittsburgh
Phase NA
Active not recruiting
220 enrolled